Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient.
about
Prostate Radiotherapy in the Era of Advanced Imaging and Precision MedicineRestriction spectrum imaging: An evolving imaging biomarker in prostate MRI.Endometrial Cancer: Combined MR Volumetry and Diffusion-weighted Imaging for Assessment of Myometrial and Lymphovascular Invasion and Tumor Grade.The expanding landscape of diffusion-weighted MRI in prostate cancerAssessment of Prostate Cancer Aggressiveness by Use of the Combination of Quantitative DWI and Dynamic Contrast-Enhanced MRI.False positive and false negative diagnoses of prostate cancer at multi-parametric prostate MRI in active surveillanceNon-small cell lung cancer: Whole-lesion histogram analysis of the apparent diffusion coefficient for assessment of tumor grade, lymphovascular invasion and pleural invasionAutomatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images.Prostate Cancer: Utility of Whole-Lesion Apparent Diffusion Coefficient Metrics for Prediction of Biochemical Recurrence After Radical Prostatectomy.Utility of histogram analysis of ADC maps for differentiating orbital tumors.Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- and High-Grade Prostate CancerValue of MR histogram analyses for prediction of microvascular invasion of hepatocellular carcinomaAssessment of Invasive Breast Cancer Heterogeneity Using Whole-Tumor Magnetic Resonance Imaging Texture Analysis: Correlations With Detailed Pathological FindingsRepeatability of derived parameters from histograms following non-Gaussian diffusion modelling of diffusion-weighted imaging in a paediatric oncological cohort.Predicting biochemical recurrence in patients with high-risk prostate cancer using the apparent diffusion coefficient of magnetic resonance imaging.Multiparametric MRI for localized prostate cancer: lesion detection and staging.Likert score 3 prostate lesions: Association between whole-lesion ADC metrics and pathologic findings at MRI/ultrasound fusion targeted biopsy.Comparison of quantitative apparent diffusion coefficient parameters with prostate imaging reporting and data system V2 assessment for detection of clinically significant peripheral zone prostate cancer.Magnetic resonance imaging for prostate cancer before radical and salvage radiotherapy: What radiation oncologists need to know.Is contrast enhancement needed for diagnostic prostate MRI?Intravoxel Incoherent Motion-derived Histogram Metrics for Assessment of Response after Combined Chemotherapy and Radiation Therapy in Rectal Cancer: Initial Experience and Comparison between Single-Section and Volumetric AnalysesMultiparametric MRI of the prostate: diagnostic performance and interreader agreement of two scoring systems.Differentiation between malignant and benign thyroid nodules and stratification of papillary thyroid cancer with aggressive histological features: Whole-lesion diffusion-weighted imaging histogram analysis.Computer-aided Detection of Prostate Cancer with MRI: Technology and Applications.Detection of Clinically Significant Prostate Cancer: Short Dual-Pulse Sequence versus Standard Multiparametric MR Imaging-A Multireader Study.Dynamic contrast-enhanced MRI of the prostate: An intraindividual assessment of the effect of temporal resolution on qualitative detection and quantitative analysis of histopathologically proven prostate cancer.MRI-Derived Restriction Spectrum Imaging Cellularity Index is Associated with High Grade Prostate Cancer on Radical Prostatectomy SpecimensPRECISION MANAGEMENT OF LOCALIZED PROSTATE CANCER.Volumetric analysis of intravoxel incoherent motion imaging for assessment of solitary pulmonary lesions.Multiparametric MRI in the Detection of Clinically Significant Prostate CancerComparison between borderline ovarian tumors and carcinomas using semi-automated histogram analysis of diffusion-weighted imaging: focusing on solid components.Assessment of prostate cancer aggressiveness using apparent diffusion coefficient values: impact of patient race and age.Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores.Relationship between Gleason score and apparent diffusion coefficients of diffusion-weighted magnetic resonance imaging in prostate cancer patients.Whole-lesion apparent diffusion coefficient histogram analysis: significance in T and N staging of gastric cancers."Textural analysis of multiparametric MRI detects transition zone prostate cancer".Association between a 17-gene genomic prostate score and multi-parametric prostate MRI in men with low and intermediate risk prostate cancer (PCa).Multi-parametric (mp) MRI of prostatic ductal adenocarcinoma.Comparison of PI-RADS 2, ADC histogram-derived parameters, and their combination for the diagnosis of peripheral zone prostate cancer.Practical aspects of prostate MRI: hardware and software considerations, protocols, and patient preparation.
P2860
Q26749961-D1CDD379-5B41-449F-BCC3-600D7AF5C8FAQ31121795-2566B360-4FE1-4FAC-AEF1-DE3995C3DEE1Q33620485-9368CFEA-46ED-4939-8B84-FBDFD7028CF8Q33762501-F146E8B4-CE70-4072-8646-752E22957971Q33821885-DA20239A-7126-448A-AF11-E7D01FC0DBE5Q35902253-E2E486CC-4AFD-4332-851C-FB3AD1CAAE67Q36282874-7187FE16-939D-46B2-B414-67469880AD4AQ36306100-0514973B-CAB0-40EE-BC2F-9F1FF42C2067Q36406333-CD25F8F2-CB2D-4C5D-9089-6F8753F2226AQ36682751-8DD396E1-1C60-4F90-8CA4-403144020518Q36727030-2FE47315-A340-4C30-8735-935C99B92B42Q37078018-9AC0215F-2605-416F-B3F5-105DC9576E6BQ37204890-876BF63E-05DF-410F-BC89-16FA902F2905Q37452768-E9014610-7559-4870-9701-3B5F9698B6FFQ37589180-6B1A20A4-AE97-44C7-A857-362A7F25880BQ38294503-35091581-CB60-43C0-B6AC-309DE587E27AQ38541412-5A433A89-2F51-40D2-BA44-9FC5B9D55FD4Q38608810-3493E56C-CD25-42D6-B9D1-10F73CF55FF6Q38636446-657A197E-DBF2-4072-A288-0C3807E32C80Q38671168-B6FCD061-7B44-470E-8E62-16BCE34EBC95Q38751651-522905F9-AB8C-4588-91CC-7447C0C2C426Q38786175-823EC7B0-395C-401A-B4AD-58CB9D498D04Q38811954-7C700114-45C3-4A4E-99E5-17B118C59FDDQ38822172-045850DE-5E24-49C9-A8F2-40819038E6EDQ38874202-8A253DE8-67DF-41B4-AB7F-01AA33C0B572Q38959728-A20C4C80-568D-4F14-8214-F3C78E6CC323Q39032764-F3E1B190-577C-49FD-920E-CFF03B80378BQ39108592-128B5921-BB36-4441-BA40-FA3D3721A3D2Q39166786-3859AF8F-DC85-47EF-89E2-AB149ABFBBFBQ39410146-0207D710-1F2D-4004-95A5-C0D3322F14ABQ40075128-2EB435D2-9E15-44C3-99D4-40A08BB72FF0Q40349425-18F48F17-891A-4CED-8495-805B120AC240Q41110614-713B627E-2CB7-4731-AE18-CD86BB91588DQ42120979-03240CEE-BE73-48EB-80DA-9D396633D053Q42200946-7AACF26C-CF81-4D0A-B577-2A8C3975F74BQ42290321-68039E54-1EB2-4CE4-80C7-735D623ABAA0Q42706784-1B889718-4693-41BF-908E-988BE8DAC12AQ44776478-0DE944AF-EA57-4868-8B21-0CE0BB57047AQ46094232-30474E34-8C08-4974-ACA7-D19718469D8CQ46567823-2BA9C20D-A4D6-4890-A081-1D76E5B44B28
P2860
Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Prostate cancer aggressiveness ...... pparent diffusion coefficient.
@en
type
label
Prostate cancer aggressiveness ...... pparent diffusion coefficient.
@en
prefLabel
Prostate cancer aggressiveness ...... pparent diffusion coefficient.
@en
P2093
P356
P1433
P1476
Prostate cancer aggressiveness ...... pparent diffusion coefficient.
@en
P2093
Chaya S Moskowitz
Hebert A Vargas
Junting Zheng
Olivio F Donati
Yousef Mazaheri
P304
P356
10.1148/RADIOL.13130973
P407
P577
2013-12-12T00:00:00Z